The big question is would TL have access to how the data was...

The big question is would TL have access to how the data was lining up? After much deliberation I am going all in on this one. I appreciate the rationale of waiting for the stock to be de risked, but in my opinion it is likely that if the ph111 is successful in the ratios stated in the Taylor Collison report then there will be little chance of getting in at a price that will reap exponential rewards. Combine that with the all star management lineup, the outcome of the ph11 trials, the quoted probability of success at approx 70% as stated by some analysts, the calibre of major shareholders I believe that on the balance of probability there will be a good outcome. So after being in this baby since the days of Meditech it is time for a reckoning one way or another. Qui audet adipiscitur!